132 related articles for article (PubMed ID: 24021930)
21. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
[TBL] [Abstract][Full Text] [Related]
22. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of KLF17 Predicts a Favorable Prognosis in Patients with Oral Squamous Cell Carcinoma: A Retrospective Study.
Lee YJ; Chan L; Yeh CM; Lee CH; Sung WW
Medicina (Kaunas); 2020 Jan; 56(2):. PubMed ID: 32019121
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer.
Kim JW; Park Y; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Int J Clin Oncol; 2016 Oct; 21(5):883-889. PubMed ID: 27000845
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
26. Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy.
Tai SK; Li WY; Yang MH; Chang SY; Chu PY; Tsai TL; Wang YF; Chang PM
Ann Surg Oncol; 2012 Jun; 19(6):1995-2002. PubMed ID: 22203180
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma.
Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CH; Chen CM; Huang CC
Oral Oncol; 2009 Sep; 45(9):798-802. PubMed ID: 19213594
[TBL] [Abstract][Full Text] [Related]
28. Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lu CF; Huang CS; Tjiu JW; Chiang CP
Head Neck; 2010 Jan; 32(1):18-25. PubMed ID: 19484765
[TBL] [Abstract][Full Text] [Related]
29. Tumor budding is an independent prognostic factor for prediction of lymph node metastasis in oral squamous cell carcinoma.
Angadi PV; Patil PV; Hallikeri K; Mallapur MD; Hallikerimath S; Kale AD
Int J Surg Pathol; 2015 Apr; 23(2):102-10. PubMed ID: 25559273
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.
Wang S; Sun M; Gu C; Wang X; Chen D; Zhao E; Jiao X; Zheng J
Eur J Oral Sci; 2014 Jun; 122(3):202-9. PubMed ID: 24796206
[TBL] [Abstract][Full Text] [Related]
32. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
33. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
34. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
[TBL] [Abstract][Full Text] [Related]
35. Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data.
Thomas B; Stedman M; Davies L
Laryngoscope; 2014 Mar; 124(3):688-94. PubMed ID: 23945976
[TBL] [Abstract][Full Text] [Related]
36. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
38. Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
Wedemeyer I; Kreppel M; Scheer M; Zöller JE; Büttner R; Drebber U
Oral Dis; 2014 Apr; 20(3):e81-9. PubMed ID: 23746299
[TBL] [Abstract][Full Text] [Related]
39. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
[TBL] [Abstract][Full Text] [Related]
40. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
